U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

Researchers from Washington University School of Medicine and Stanford University have developed a compound that simulates a ...

Researchers create a cannabis-derived compound that relieves pain without the risk of addiction or mind-altering effects.

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating ...

Evidence is stacking up about the influence of cannabinoids on cardiovascular disease, and newer, synthetic options are ...

They bind to a receptor, called cannabinoid receptor one (CB1), on the surface of brain cells and on pain-sensing nerve cells throughout the body. Working with collaborators at Stanford University, co ...

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain. The drug, known as VIP36, targets the body’s ...

For centuries, people have used marijuana to treat pain, but its psychoactive effects (such as mood changes and cognitive ...

whether signalling bias could be the key to accessing pain relief without adverse effects. Although the CB1 receptor is structurally similar to the µ-opioid receptor because they are both GPCRs ...

"This drug has significant implications for chronic pain treatment via peripheral CB1 activation but also could revolutionize the design of drugs targeting other [pain receptors]." The other ...

They bind to a receptor, called cannabinoid receptor one (CB1), on the surface of brain cells and on pain-sensing nerve cells throughout the body. Working with colleagues at Stanford University, ...